Basically The Most Ignored Problem Of SNS-032

In another study Han et al., used the water extract of Solanum melongena which inhibited PAR-2 mediated myeloperoxidase activity and tissue necrosis factor-�� [19]. The leaves of Solanum melongena Linn contain flavonoids, alkaloids, tannins and sterols. Various flavonoids, glycosides and aglycones were previously reported as having potent anti-inflammatory activity. Pourmotabbed et al., suggested that some flavonoids blocks both cyclooxygenase and lipoxygenase pathway of the arachidonate cascade at high concentration, while at low concentration only lipoxygenase pathway [20]. Salerno L et al., found out flavonoids present in 50% aqueous and 50% ethanol extract of skin of Solanum melongena fruit contains anti-oxidant property [21]. Also there are few reports on the role of tannins in anti-inflammatory activity [22]. In the present study the anti-inflammatory activity of Solanum melongena Linn might be due to the presence PHA-665752 concentration of flavonoids and tannins. Conclusion From the present study we come to the conclusion that the extract of S.melongena Linn possesses anti-inflammatory activity in experimental animals. The present study also substantiates the traditional use of S.melongena Linn for the treatment of various inflammatory ailments. The plant can be recommended for the further studies to isolate the active ingredients. Notes Financial or Other Competing Interests None.Objectives: Prevalence of opioid addiction has alarmingly increased over the recent years. In South Asian region Mannose-binding protein-associated serine protease alone there are more than 10 million opioid abusers amounting to 2% of world population. Detoxification remains to be the first step for the successful treatment of opioid addiction. The present study was carried out to compare the relative efficacy and safety of buprenorphine �Cnaloxone and clonidine hydrochloride in the detoxification of opioid-dependents. Materials and Methods: Present trial was conducted at De- addiction centre of Institute of Mental and Neurosciences (IMNS), GMC Srinagar. Fifty four (54) treatment seeking subjects, 15-50 years of age, fulfilling DSM-1V TR (American Psychiatric association`s Mental Disorders-1V SNS-032 molecular weight text revision) criteria for opioid dependence were included and randomized into two groups. The groups received either clonidine hydrochloride (Group A) or buprenorphine- naloxone (Bup-Nax) (Group B) for the duration of 10 days. The efficacy of the two drugs in controlling the opioid withdrawal was evaluated by Clinical Opioid Withdrawal Scale (COWS) and their effect on the desire for the abused substance was measured by Visual Analogue Scale (VAS). The safety of the two drugs was measured by taking the side effect profile of the two compared drugs into consideration. Results: There was significant difference of COWS-score between the two groups which was evident from day 3 (14.85 �� 3.43 vs. 11.67 �� 2.40, p